CAS Medical

CAS Medical Systems, commonly known as CASMED, was a medical technology company that specialized in non-invasive monitoring of tissue oxygenation. The company's flagship product, the FORE-SIGHT Absolute Tissue Oximeter, utilized near-infrared spectroscopy to provide clinicians with precise, non-invasive measurements of cerebral oxygen saturation. This technology is critical for detecting and preventing brain hypoxia during complex surgical procedures and in neonatal intensive care units. In April 2019, the company was acquired by Edwards Lifesciences for approximately $100 million, integrating its oximetry solutions into Edwards' broader hemodynamic monitoring portfolio.